Finasteride Tablet, Film Coated
Product Images NDC 68788-8433

7 FDA label images from Preferred Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 68788-8433). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structutre (Finasteride Structure)

Structutre (Finasteride Structure)
Chemical structure diagram of finasteride, showing its steroidal backbone with multiple rings, methyl groups, and carbonyl functional groups, consistent with the labeled active ingredient finasteride.*
FDA Label Image

Finasteride Figure 1 (Finasteride Fig.1.jpg.jpg)

Finasteride Figure 1 (Finasteride Fig.1.jpg.jpg)
A line chart showing the mean change from baseline with standard error over four years comparing Finasteride tablets 5 mg with placebo. The x-axis represents time points from baseline to year 4, and the y-axis represents mean change values. Two lines depict data for Finasteride and placebo groups with sample sizes noted for each year.*
FDA Label Image

Finasteride Figure 2 (Finasteride Fig.3.jpg.jpg)

Finasteride Figure 2 (Finasteride Fig.3.jpg.jpg)
A line graph comparing mean percent change from baseline over 4 years between placebo and finasteride groups. The vertical axis shows mean percent change plus/minus one standard error, and the horizontal axis represents time points: baseline, year 1, year 2, year 3, and year 4. Placebo data points increase positively over time, while finasteride data points decrease negatively. Sample sizes for each group at each time point are provided below the timeline.*
FDA Label Image

Finasteride-fig.3_ (Fig 3finasteride)

Finasteride-fig.3_ (Fig 3finasteride)
A line graph depicting the cumulative percent of patients over 48 months for two groups: Finasteride and Placebo. The x-axis shows observation time in months, and the y-axis shows percent of patients, ranging from 0% to 15%. The graph includes a table reporting the number of events and patients at risk per year for both groups.*
FDA Label Image

Finasteride Figure 4 (Finasteride Fig.4.jpg.jpg)

Finasteride Figure 4 (Finasteride Fig.4.jpg.jpg)
A line graph showing the percent of participants with an event over 5.5 years from randomization, comparing treatment groups Placebo, Finasteride, Doxazosin, and Combination. The y-axis is labeled 'Percent with Event' (0 to 25), and the x-axis is labeled 'Years from Randomization' (0 to 5.5). Placebo shows the highest event percentage, followed by Finasteride, Doxazosin, and Combination, which is lowest.*
FDA Label Image

Finasteride-fig.2 (Finasteride Fig.2.jpg.jpg)

Finasteride-fig.2 (Finasteride Fig.2.jpg.jpg)
A line graph comparing the percent of patients over 48 months in Finasteride and Placebo groups. The y-axis shows percent of patients (0-15%), and the x-axis shows observation time in months (0-48). Solid line represents Finasteride with lower event rates; dashed line represents Placebo with higher event rates. Below the graph, cumulative number of events and number at risk per year are listed for each group.*
FDA Label Image

Finasteride Tablets Usp 5mg (Finasteride 5mg 30tab)

Finasteride Tablets Usp 5mg (Finasteride 5mg 30tab)
Finasteride Tablets, USP 5 mg film-coated tablet packaging label manufactured by Preferred Pharmaceuticals, Inc. The label states the product is generic for Proscar and includes storage instructions, a caution about misuse, and manufacturer details as Ascend Laboratories, LLC. It has space for lot, batch, expiration date, and quantity details. Directions are provided in English and Spanish on a yellow background area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.